Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey
Table 1
Hypertension classification in the SCORE-eligible contingent of POWER ( = 12,718).
Patient population
Male ()
Female ()
Total population ( = 12,718)
Patients contributing data
6477
6172
12,649
Isolated systolic hypertension; (%)
1296 (20.0)
1515 (24.5)
2811 (22.2)
Isolated diastolic hypertension; (%)
92 (1.4)
58 (0.9)
150 (1.2)
Systodiastolic hypertension; (%)
5026 (77.6)
4529 (73.4)
9555 (75.5)
No hypertension (SBP <140 mmHg and DBP <90 mmHg); (%)
